PUMA BIOTECHNOLOGY, INC.

PBYINasdaq· Pharmaceutical Preparations

Price History

Revenue

$228.4M

▼ 0.9% YoY

Net Income

$31.1M

▲ 2.8% YoY

EPS

$0.61

▼ 1.6% YoY

Cash

$29.6M

▼ 57.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.